Omada Health (OMDA) Financial Ratios
4 years of historical data (2022–2025) · Healthcare · Medical - Healthcare Information Services
EV/EBITDA
N/A
—
5yr avg: N/A
P/FCF
61.94
+14% vs avg
5yr avg: 54.46
30Y Low54.5·High54.5
P/B Ratio
4.49
+12% vs avg
5yr avg: 4.01
30Y Low4.0·High4.0
ROE
↑
-8.7%
↓+79% vs avg
5yr avg: -41.5%
30Y Low-58%·High-9%
Debt/EBITDA
N/A
—
5yr avg: N/A
Percentile shows where the current value sits in 30-year historical distribution. Sparklines show 5-year trend.
OMDA Valuation Multiples
Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow
Omada Health currently has a negative P/E ratio, indicating the company is operating at a loss on a trailing-twelve-month basis. On a free-cash-flow basis, the stock trades at 61.9x P/FCF, 14% above the 5-year average of 54.5x.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
| Market Cap | $1.0B | $922M | — | — | — |
| Enterprise Value | $827M | $700M | — | — | — |
| P/E Ratio → | -80.18 | — | — | — | — |
| P/S Ratio | 4.03 | 3.54 | — | — | — |
| P/B Ratio | 4.49 | 4.01 | — | — | — |
| P/FCF | 61.94 | 54.46 | — | — | — |
| P/OCF | 57.46 | 50.52 | — | — | — |
P/E links to full P/E history page with 30-year chart
OMDA EV Ratios
Enterprise-value multiples — capital-structure-neutral measures of total business value
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
| EV / Revenue | — | 2.69 | — | — | — |
| EV / EBITDA | — | — | — | — | — |
| EV / EBIT | — | — | — | — | — |
| EV / FCF | — | 41.35 | — | — | — |
OMDA Profitability
Margins and return-on-capital ratios measuring operating efficiency
Omada Health earns an operating margin of -4.6%. Operating margins have expanded from -53.8% to -4.6% over the past 3 years, signaling improving operational efficiency. A negative ROE of -8.7% indicates the company is currently destroying shareholder equity.
Margins
Full margin charts and quarterly trend are on the Earnings History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
| Gross Margin | 65.7% | 65.7% | 60.6% | 57.0% | 48.0% |
| Operating Margin | -4.6% | -4.6% | -25.7% | -53.8% | -81.1% |
| Net Profit Margin | -4.9% | -4.9% | -27.8% | -55.0% | -81.3% |
Return on Capital
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
| ROE | -8.7% | -8.7% | -57.6% | -53.0% | -46.6% |
| ROA | -5.6% | -5.6% | -28.9% | -34.0% | -32.7% |
| ROIC | -68.9% | -68.9% | -202.8% | -307.9% | — |
| ROCE | -7.3% | -7.3% | -38.3% | -41.4% | -38.6% |
OMDA Leverage & Debt
Solvency and debt-coverage ratios — lower is generally safer
The company holds a net cash position — cash of $222M exceeds total debt of $0, providing substantial financial flexibility for buybacks, acquisitions, or weathering downturns.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
| Debt / Equity | — | — | 0.47 | 0.31 | 0.20 |
| Debt / EBITDA | — | — | — | — | — |
| Net Debt / Equity | — | -0.97 | -0.71 | -0.86 | -0.88 |
| Net Debt / EBITDA | — | — | — | — | — |
| Debt / FCF | — | -13.11 | — | — | — |
| Interest Coverage | -4.04 | -4.04 | -9.46 | -13.35 | -16.26 |
Net cash position: cash ($222M) exceeds total debt ($0)
OMDA Liquidity & Efficiency
Short-term solvency ratios and asset-utilisation metrics
Omada Health's current ratio of 3.60x is well above the 1.0 safety threshold, indicating strong short-term liquidity with ample room to cover current liabilities. The current ratio has improved from 3.26x to 3.60x over the past 3 years.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
| Current Ratio | 3.60 | 3.60 | 2.10 | 3.26 | 5.46 |
| Quick Ratio | 3.54 | 3.54 | 2.03 | 3.18 | 5.36 |
| Cash Ratio | 2.93 | 2.93 | 1.42 | 2.64 | 4.87 |
| Asset Turnover | — | 0.85 | 1.13 | 0.70 | 0.40 |
| Inventory Turnover | 19.90 | 19.90 | 20.30 | 14.61 | 13.11 |
| Days Sales Outstanding | — | 48.51 | 51.42 | 48.87 | 47.75 |
OMDA Shareholder Yields
Earnings, FCF, buyback, and dividend yields — total returns to shareholders
Omada Health does not currently pay a dividend and has no material buyback yield, reinvesting earnings back into the business.
Dividends
Full dividend history and growth charts are on the Dividend History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
| Dividend Yield | — | — | — | — | — |
| Payout Ratio | — | — | — | — | — |
Total Shareholder Return Metrics
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
| Earnings Yield | — | — | — | — | — |
| FCF Yield | 1.6% | 1.8% | — | — | — |
| Buyback Yield | 0.0% | 0.0% | — | — | — |
| Total Shareholder Yield | 0.0% | 0.0% | — | — | — |
| Shares Outstanding | — | $58M | $56M | $56M | $56M |
Peer Comparison
Compare OMDA with 10 similar companies in its peer group
| Company | Market Cap | P/E | EV/EBITDA | P/FCF | Gross Margin | Op Margin | ROE | ROIC | Debt/EBITDA |
|---|---|---|---|---|---|---|---|---|---|
 OMDAYou | $1B | -80.2 | — | 61.9 | 65.7% | -4.6% | -8.7% | -68.9% | — |
 HIMS | $8B | 69.5 | 55.1 | 105.3 | 73.8% | 4.5% | 25.2% | 8.6% | 7.9 |
 NVCR | $2B | -11.7 | — | — | 74.5% | -23.5% | -38.9% | -16.4% | — |
 TDOC | $1B | -7.1 | 17.1 | 5.1 | 69.5% | -10.4% | -13.9% | -11.5% | 10.4 |
 OPRX | $93M | 18.4 | 5.9 | 5.0 | 63.3% | 11.0% | 4.2% | 6.8% | 1.6 |
 GDRX | $922M | 31.2 | 4.2 | 5.6 | 92.8% | 11.0% | 4.5% | 10.6% | 0.3 |
 PHVS | $2B | -9.7 | — | — | — | — | -65.2% | — | — |
 DOCS | $4B | 20.9 | 16.8 | — | 89.1% | 33.3% | 19.3% | 19.8% | 0.0 |
 AMWL | $141M | -1.4 | — | — | 53.3% | -42.2% | -33.9% | -95.1% | — |
 TALK | $873M | 130.3 | 138.6 | — | 43.0% | 1.4% | 6.6% | 3.9% | — |
 CVS | $125B | 70.7 | 14.0 | 16.1 | 13.8% | 2.6% | 2.3% | 5.0% | 6.2 |
| Healthcare Median | — | 22.1 | 14.2 | 18.5 | 63.9% | -4.3% | -32.6% | -11.6% | 3.2 |
Peer selection based on competitive and market overlap. Compare multiple stocks →
Download Financial Ratios Data
Includes 30+ ratios · 4 years · Updated daily
Consensus-Based Analysis Tools
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Check Valuation
Historical Returns
10-year return with dividends reinvested.
Calculate
DCA Calculator
See how regular investing compounds over time.
Run Numbers
Peer Comparison
Compare growth, multiples, and margins vs sector.
Compare
OMDA — Frequently Asked Questions
Quick answers to the most common questions about buying OMDA stock.
What is Omada Health's P/E ratio?
Omada Health's current P/E ratio is -80.2x. This places it at the 50th percentile of its historical range.
What is Omada Health's ROE?
Omada Health's return on equity (ROE) is -8.7%. The historical average is -41.5%.
Is OMDA stock overvalued?
Based on historical data, Omada Health is trading at a P/E of -80.2x. This is at the 50th percentile of its historical P/E range. Compare with industry peers and growth rates for a complete picture.
What are Omada Health's profit margins?
Omada Health has 65.7% gross margin and -4.6% operating margin.